NMDA antagonists (Hokkaido University/Asahi Kasei)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameNMDA antagonists (Hokkaido University/Asahi Kasei)
Drug Alias Namemilnacipran analogs (Hokkaido University/Asahi Kasei)PPDC analogs (Hokkaido University/Asahi Kasei)PPDC
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlutamate [NMDA] receptor antagonists
TargetsGlutamate [NMDA] receptor
Therapy Area/IndicationsNerve Degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesHokkaido University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAsahi Kasei Pharma CorpHokkaido University
Active IndicationsN/A
Inactive IndicationsNerve Degeneration

Other Information

ATC CodeN/A
Related LinksN/A